Fast-Tracking Drug Development and Scale-Up in the Post-Covid World

webinar

Development Process Development

The webinar focuses on truncating drug development timelines in the aftermath of COVID-19. The featured speaker emphasizes phase-appropriate development, offering creative solutions and round-the-clock development across various continents.

The webinar also highlights tech transfer into various sites within the Curia network. Using a global sourcing team to find raw materials that have a diversified supply chain, the speaker will discuss how they have adapted and learnt lessons from the Covid outbreak.

Join this webinar to learn how to accelerate drug development timelines in the post-Covid era.

Want to keep the conversation going?
Schedule a meeting with our experts today!

Ready to move from idea to impact?

Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.

More from Curia

publications patents

Poster: In Vitro Characterization of a Dual Antagonistic Anti-LILRB2/LILRB4 Monoclonal Antibody

We have identified a dual antiLILRB2/LILRB4 antagonist. Targeting MDSCs with this antibody offers great promise for immunotherapy for cancer as well as its immense potential for synergy with PD-1 blockade.

article

Trends and Challenges in the Pharmaceutical Industry

Significant changes have taken place in the life sciences industry over the past few years. Since the Covid-19 pandemic, the U.S. government has urged biotech and pharmaceutical companies to increase domestic production in order to secure the drug su...